Sign In
Buy SYK
$335.96
-5.24 (-1.54%)
At Close: Aug 04, 2026
Stryker's (SYK) Acquisition of Artelon Set to Expand Its Market
01:40pm, Tuesday, 04'th Jun 2024
Stryker (SYK) announces the signing of the definitive agreement to acquire a privately held company, Artelon, to strengthen its foothold in the soft tissue fixation market.
Stryker releases LIFEPAK 35 monitor/defibrillator
09:05am, Tuesday, 04'th Jun 2024
LIFEPAK 35, a clinically advanced monitor/defibrillator, reduces caregiver burden and streamlines workflow.1 PORTAGE, Mich., USA, June 4, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in m
KALAMAZOO, Mich.--(BUSINESS WIRE)--Stryker announced the signing of a definitive agreement to acquire all of the issued and outstanding shares of Artelon.
Stryker (SYK) to Launch Gamma4 Hip Fracture System in Europe
12:56pm, Thursday, 30'th May 2024
Stryker (SYK) announces plan to launch its Gamma4 Hip Fracture Nailing System in Europe. It completes initial surgeries successfully.
The 3 Best MedTech Stocks to Buy Now: May 2024
02:30pm, Wednesday, 29'th May 2024
In a recent deep-dive research report on the state of the MedTech (medical technology) sector, Oppenheimer highlighted the potential of artificial intelligence (AI) in the sector, noting its capacity
Stryker (SYK) Issues Safety Notice for Its Total Knee System
02:06pm, Wednesday, 29'th May 2024
Stryker (SYK) issues urgent field safety notice for the Mako Total Knee systems, the application software of which generated software error codes. The company also shares risk mitigation steps.
First European Surgeries Completed Using Stryker's Gamma4 Hip Fracture Nailing System
02:10am, Wednesday, 29'th May 2024
AMSTERDAM, Netherlands--(BUSINESS WIRE)--The first surgeries utilizing Stryker's Gamma4 Hip Fracture Nailing System were completed in Europe.
HealthTech Heroes: 3 Medical Technology Stocks to Buy Before They Boom
02:15pm, Tuesday, 28'th May 2024
While the biotechnology sector may receive most of the attention under the broad healthcare umbrella, investors ought to spare some love for medical technology stocks. The enterprises undergirding the
3 Robotics Stocks to Buy Now: May 2024
06:30am, Thursday, 23'rd May 2024
Automation continues to be a key driving force of technological innovation in the 21st century. Older industrial sectors have relied on automation for driving efficiencies across the use of various eq
Inside information: Alan Donze has been appointed as Bioretec's new CEO
11:23am, Monday, 20'th May 2024
Bioretec Ltd Inside information 20 May 2024 at 6:00 p.m. EEST TAMPERE, Finland, May 20, 2024 /PRNewswire/ -- Bioretec Ltd is pleased to announce that Mr. Alan Donze has been appointed CEO of Bioretec
Inside information: Alan Donze has been appointed as Bioretec's new CEO
11:18am, Monday, 20'th May 2024
Bioretec Ltd Inside information 20 May 2024 at 6:00 p.m. EEST TAMPERE, Finland, May 20, 2024 /PRNewswire/ -- Bioretec Ltd is pleased to announce that Mr. Alan Donze has been appointed CEO of Bioretec
Stryker declares a $0.80 per share quarterly dividend
08:00am, Thursday, 09'th May 2024
Portage, Michigan, May 09, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable July 31, 2024 to shareholders
First Surgeries Using Stryker's Infinity With Adaptis and Everlast Successfully Completed in Europe
02:10am, Tuesday, 07'th May 2024
AMSTERDAM--(BUSINESS WIRE)--Stryker announced the completion of the first European surgeries using the Infinity Total Ankle System with Adaptis and Everlast technology.
Stryker's (SYK) Q1 Earnings Beat Estimates, Guidance Raised
10:16am, Wednesday, 01'st May 2024
Stryker's (SYK) first-quarter earnings reflect strong performance across its segments and geographies. Operating and gross margins increase, with earnings and revenues beating their respective estimat
Stryker Corporation (SYK) Q1 2024 Earnings Call Transcript
08:30pm, Tuesday, 30'th Apr 2024
Start Time: 16:30 January 1, 0000 5:28 PM ET Stryker Corporation (NYSE:SYK ) Q1 2024 Earnings Conference Call April 30, 2024, 16:30 PM ET Company Participants Kevin Lobo - Chair and CEO Glenn Boehnlei
